Atomic view of Alzheimer's disease peptide could inform new drugs
One of the hallmarks of Alzheimer's disease is the accumulation of a peptide in the brain known as amyloid beta. A new study published in Nature Communications on July 22 has uncovered the atomic structure of the peptide in its harmful form.
One of the hallmarks of Alzheimer's disease is the accumulation of a peptide in the brain known as amyloid beta. A new study published in Nature Communications on July 22 has uncovered the atomic structure of the peptide in its harmful form. This story matters for Science & Discovery readers tracking student. Reported by phys.org. Read the full original at the source link below.
Originally reported by phys.org. StudentNews curates and briefs the science & discovery stories that matter. Our editorial policy →